-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OZSDmEks9uU4qZb7cOEkXH8Nl8EjR6Rwx5k7diDTE1BCNJyWNO3jGD3/YVlMXKSD rJJpOFK8efPO1XylrTsZYg== 0001209191-11-011667.txt : 20110222 0001209191-11-011667.hdr.sgml : 20110221 20110222180232 ACCESSION NUMBER: 0001209191-11-011667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110217 FILED AS OF DATE: 20110222 DATE AS OF CHANGE: 20110222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONWAY ANTHONY J CENTRAL INDEX KEY: 0001033088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18933 FILM NUMBER: 11629896 MAIL ADDRESS: STREET 1: 1500 SECOND AVE NW CITY: STEWARTVILLE STATE: NC ZIP: 55976 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ROCHESTER MEDICAL CORPORATION CENTRAL INDEX KEY: 0000868368 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411613227 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: ONE ROCHESTER MEDICAL DR CITY: STEWARTVILLE STATE: MN ZIP: 55976 BUSINESS PHONE: 5075339600 MAIL ADDRESS: STREET 1: ONE ROCHESTER MEDICAL DR CITY: STEWARTVILLE STATE: MN ZIP: 55976 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-02-17 0 0000868368 ROCHESTER MEDICAL CORPORATION ROCM 0001033088 CONWAY ANTHONY J 500 PROSPECT STREET CHATFIELD MN 55923 1 1 0 0 President and Secretary Common Stock 63755 I By Spouse Common Stock 2011-02-17 4 M 0 30000 2.3595 A 828104 D Common Stock 2011-02-17 4 M 0 4000 2.344 A 832104 D Common Stock 2011-02-17 4 S 0 34000 10.7523 D 798104 D Common Stock 2011-02-18 4 M 0 7700 2.344 A 805804 D Common Stock 2011-02-18 4 S 0 7700 10.7103 D 798104 D Common Stock 2011-02-22 4 M 0 8300 2.344 A 806404 D Stock Option (Right to Buy) 2.3595 2011-02-17 4 M 0 13184 0.00 D 2011-03-12 Common Stock 13184 0 D Stock Option (Right to Buy) 2.3595 2011-02-17 4 M 0 16816 0.00 D 2011-03-12 Common Stock 16816 0 D Stock Option (Right to Buy) 2.344 2011-02-17 4 M 0 4000 0.00 D 2011-04-06 Common Stock 10000 6000 D Stock Option (Right to Buy) 2.344 2011-02-18 4 M 0 6000 0.00 D 2011-04-06 Common Stock 6000 0 D Stock Option (Right to Buy) 2.344 2011-02-18 4 M 0 1700 0.00 D 2011-04-06 Common Stock 10000 8300 D Stock Option (Right to Buy) 2.344 2011-02-22 4 M 0 8300 0.00 D 2011-04-06 Common Stock 8300 0 D Stock Option (Right to Buy) 2.165 2011-10-16 Common Stock 15000 15000 D Stock Option (Right to Buy) 2.165 2011-10-16 Common Stock 15000 15000 D Stock Option (Right to Buy 4.125 2004-01-02 2013-01-02 Common Stock 16000 16000 D Stock Option (Right to Buy) 4.625 2005-01-02 2014-01-02 Common Stock 16000 16000 D Stock Option (Right to Buy) 4.70 2006-01-01 2015-01-01 Common Stock 40000 40000 D Stock Option (Right to Buy) 5.70 2007-01-26 2016-01-26 Common Stock 1844 1844 D Stock Option (Right to Buy) 5.70 2007-01-26 2016-01-26 Common Stock 18156 18156 D Stock Option (Right to Buy) 12.30 2007-11-21 2016-11-21 Common Stock 40000 40000 D Stock Option (Right to Buy) 11.23 2009-02-06 2018-02-06 Common Stock 30000 30000 D Stock Option (Right to Buy) 11.27 2010-02-03 2019-02-03 Common Stock 30000 30000 D Stock Option (Right to Buy) 12.27 2011-01-28 2020-01-28 Common Stock 30000 30000 D Stock Option (Right to Buy) 10.72 2012-01-27 2021-01-27 Common Stock 30000 30000 D The price in Column 4 is a weighted average. The prices actually received ranged from $10.70 to $10.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average. The prices actually received ranged from $10.60 to $10.82. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. 100% vested. Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown. 100% vested on 1/26/2007. Vest 3,156 shares on 1/26/2007 and annual cumulative installments of 5,000 beginning 1/26/2008. David A. Jonas, as Attorney-in-Fact for Anthony J. Conway 2011-02-22 -----END PRIVACY-ENHANCED MESSAGE-----